TrialThe oncologist2023

Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab.

Charlotte Manogue Hawkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.